Author
The author works as a Correspondent with BW Businessworld
In an exclusive interaction with BW Healthcare World, Dr Mahesh Kappanayil, Clinical Professor of Paediatric Cardiology at Amrita Hospital spoke on the evolving technologies, their use cases in hospitals as well as in medical education and the dream of having an artificial heart in the near future
Read More
The global leaders said that they remain committed to fortifying the global health architecture with the World Health Organization (WHO) at its core and building more resilient, equitable, sustainable, and inclusive health systems to achieve Universal Health Coverage
Read More
In the latest drug alert for the month of July, the Central Drug Standard Control Organisation (CDSCO) has flagged as many as 51 drug formulations from top pharma giants such as Cipla, Sun Pharma and Alkem Health Science among others.
Read More
In terms of annual Scope 2 Greenhouse Gas (GHG) emissions, hospitals released 7.7 million tonnes of carbon dioxide (CO2) into the atmosphere in the financial year of 2019 to 2020. Scope 2 emissions are indirect emissions produced by purchased energy that an organisation buys and consumes
Read More
In a new notification dated 23 August 2023, the National Medical Commission has set aside its earlier regulations released on 2nd of August which mandated doctors to prescribe generic drugs over branded ones and barred the clinicians from receiving any gifts or endorsements from pharmaceutical companies
Read More
Bangalore-based pharmaceutical company Biocon on Thursday announced its consolidated financial results for the first quarter that ended 30 June 2023, the company registered a 58 per cent rise in its consolidated revenues from operations year on year
Read More
The race to strip your weight has already begun with pharmaceutical companies, digital healthcare firms and medical device organisations racing to prepare a shelf full of solutions that includes medicines, devices and digital therapeutics. The opportunity to bring these solutions for obesity is also immense as half of the world is said to be overweight and obese by 2030
Read More
The report has revealed major discrepancies subsuming fake beneficiaries using the same IDs for multiple uses, unqualified hospitals empanelled under the PMJAY scheme, inconsistency in claim settlements and financial management and insufficient grievance redressal mechanisms across the country
Read More
In India, the Danish drug maker Novo Nordisk is the market leader and presently claims around 60 per cent of the country’s insulin supply. Speaking to BW Businessworld in an exclusive interaction, John C Dawber, CVP and MD, Global Business Services talks about the company’s GLP1 growth story, the market of obesity drugs and their safety profile and building capacities and partnerships
Read More
In India overuse and misuse of medications in older adults is a major cause for concern and the rising culture of unnecessary prescribing of medications may enhance the risk of adverse outcomes
Read More
